Transition metal
carbides (TMCs) have demonstrated outstanding
potential for utilization in a wide range of catalytic applications
because of their inherent multifunctionality and tunable composition.
However, the harsh conditions required to prepare these materials
have limited the scope of synthetic control over their physical properties.
The development of low-temperature, carburization-free routes to prepare
TMCs would unlock the versatility of this class of materials, enhance
our understanding of their physical properties, and enable their cost-effective
production at industrial scales. Here, we report an exceptionally
mild and scalable solution-phase synthesis route to phase-pure molybdenum
carbide (α-MoC1–x
) nanoparticles
(NPs) in a continuous flow millifluidic reactor. We exploit the thermolytic
decomposition of Mo(CO)6 in the presence of a surface-stabilizing
ligand and a high boiling point solvent to yield MoC1–x
NPs that are colloidally stable and resistant to
bulk oxidation in air. To demonstrate the utility of this synthetic
route to prepare catalytically active TMC NPs, we evaluated the thermochemical
CO2 hydrogenation performance of α-MoC1–x
NPs dispersed on an inert carbon support. The α-MoC1–x
/C catalyst exhibited a 2-fold increase
in both activity on a per-site basis and selectivity to C2+ products as compared to the bulk α-MoC1–x
analogue.
Ex situ catalytic fast pyrolysis of biomass is a promising route for the production of fungible liquid biofuels. There is significant ongoing research on the design and development of catalysts for this process. However, there are a limited number of studies investigating process configurations and their effects on biorefinery economics. Herein we present a conceptual process design with techno-economic assessment; it includes the production of upgraded bio-oil via fixed bed ex situ catalytic fast pyrolysis followed by final hydroprocessing to hydrocarbon fuel blendstocks. This study builds upon previous work using fluidized bed systems, as detailed in a recent design report led by the National Renewable Energy Laboratory (NREL/ TP-5100-62455); overall yields are assumed to be similar, and are based on enabling future feasibility. Assuming similar yields provides a basis for easy comparison and for studying the impacts of areas of focus in this study, namely, fixed bed reactor configurations and their catalyst development requirements, and the impacts of an inline hot gas filter. A comparison with the fluidized bed system shows that there is potential for higher capital costs and lower catalyst costs in the fixed bed system, leading to comparable overall costs. The key catalyst requirement is to enable the effective transformation of highly oxygenated biomass into hydrocarbons products with properties suitable for blending into current fuels. Potential catalyst materials are discussed, along with their suitability for deoxygenation, hydrogenation and C-C coupling chemistry. This chemistry is necessary during pyrolysis vapor upgrading for improved bio-oil quality, which enables efficient downstream hydroprocessing; C-C coupling helps increase the proportion of diesel/jet fuel range product. One potential benefit of fixed bed upgrading over fluidized bed upgrading is catalyst flexibility, providing greater control over chemistry and product composition. Since this study is based on future projections, the impacts of uncertainties in the underlying assumptions are quantified via sensitivity analysis. This analysis indicates that catalyst researchers should prioritize by: carbon efficiency [ catalyst cost [ catalyst lifetime, after initially testing for basic operational feasibility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.